Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01566903 : Neurovascular Non Contrast-Enhanced MR Angiography at 3T
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Men and women over 18 years

- Any adult patient known or clinically suspect to present a neurovascular disease
(arterial stenosis ou arteriovenous malformations), the assessment of which requires
an MRA or patient having an arteriovenous malformation for which treatment by
embolization or radiosurgery is indicated multidisciplinary meeting and followed in
the ordinary course of this treatment

- Patient able of accepting protocol information

- Patient who received information about the protocol and had not expressed its
opposition to participate

Exclusion Criteria:

- A contraindication to MRI, in particular pacemakers or implantable defibrillators,
cochlear implants, neurosurgical clips, intra-orbital or brain metallic foreign
bodies, endo prothesis since less than 4 weeks or osteosynthesis material since less
than 6 weeks

- Contraindication to the injection of contrast agent: pregnancy, lactation, history of
allergic reaction to contrast agent injection

- Hemodynamically unstability, acute respiratory failure, a precarious condition or a
need for continuous monitoring incompatible with the constraints of MR imaging

- Patient with severe kidney with Glomerular Filtration rate < 30 ml/min

- Persons subject to major legal protection (safeguarding justice, guardianship,
trusteeship), persons deprived of liberty
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557